SWOT Analysis for Dr. Agarwals Health Care Ltd.

Relative Outperformance versus Industry over 1 Week
Growth in Net Profit with increasing Profit Margin (QoQ)
Company with Low Debt
Increasing Revenue every Quarter for the past 4 Quarters
Increasing profits every quarter for the past 2 quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Book Value per share Improving for last 2 years
Company with Zero Promoter Pledge
RSI indicating price strength
Stocks near 52 Week High with Significant Volumes
Stocks Outperforming their Industry Price Change in the Quarter

PE higher than Industry PE
Expensive Underperformers (DVM)
High PE (PE > 40)
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Lowest Momentum Scores (Technical Scores)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of capital to generate profits - RoCE declining in the last 2 years
Inefficient use of shareholder funds - ROE declining in the last 2 years
Declining Net Cash Flow : Companies not able to generate net cash
Increasing Trend in Non-Core Income
Top Losers
Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV